Preneoplastic and neoplastic lesions in rodent liver show alterations in the expression of various enzymes which can be used for their identification. To address the question whether these enzymatic alterations result from specific changes in the levels of hepatocyte-enriched nuclear factors (HNF), we analysed the mRNA levels of six different HNFs (HNF-la, P, HNF-3a, P, y, and HNF-4) by RNase protection assay in chemically induced liver tumours and corresponding normal liver tissue from mice of three different strains. When compared with the normal liver tissue, HNF-ip, HNF-3a and HNF-3p showed unchanged expression levels in the various liver tumours, while HNF-la and HNF-4 mRNAs were lowered by 20-30%, and HNF-3ymRNA was increased by 50%. There were no significant differences in HNF-expression between tumours harbouring point mutations at codon 61 of the Ha-ras protooncogene and tumours without detectable Ha-ras mutations.
Preneoplastic and neoplastic lesions in rodent liver show alterations in the expression of various enzymes which can be used for their identification. To address the question whether these enzymatic alterations result from specific changes in the levels of hepatocyte-enriched nuclear factors (HNF), we analysed the mRNA levels of six different HNFs (HNF-la, P, HNF-3a, P, y, and HNF-4) by RNase protection assay in chemically induced liver tumours and corresponding normal liver tissue from mice of three different strains. When compared with the normal liver tissue, HNF-ip, HNF-3a and HNF-3p showed unchanged expression levels in the various liver tumours, while HNF-la and HNF-4 mRNAs were lowered by 20-30%, and HNF-3ymRNA was increased by 50%. There were no significant differences in HNF-expression between tumours harbouring point mutations at codon 61 of the Ha-ras protooncogene and tumours without detectable Ha-ras mutations.
Hepatocarcinogenesis in rodents is characterized by the sequential appearance of preneoplastic and neoplastic populations of cells in the liver which show, in comparison to their normal counterparts, alterations in their proliferation behaviour and changes in the expression and activity of a large number of different enzymes (for recent reviews see 1,2). Many of the genes that show altered expression levels in the transformed liver cells are transcribed at particularly high levels in the normal liver and are characteristic of the differentiated phenotype of the hepatocyte. Among these are genes coding for enzymes involved in drug metabolism, including various cytochome P450 isozymes, glutathione S-transferases, epoxide hydrolases, sulphotransferases and glucuronosyltransferases. Alterations in the activity of key enzymes of carbohydrate metabolism, like glucose-6-phosphatase, glucose-6-phosphate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase, may result in excessive glycogen accumulation in the preneoplastic cell population, while neoplastically transformed hepatocytes generally lose the ability to store glycogen. Albumin synthesis and secretion is often found to be decreased in transformed hepatocytes, while cc-fetoprotein, normally only expressed during fetal development, is sometimes upregulated in advanced carcinomas in the liver. Hepatocellular foci and nodules in rats and mice are phenotypically heterogeneous, indicating the existence of distinct subpopulations of lesions.
•Abbreviations: HNF, hepatocyte-enriched nuclear factor, DEN, /V-nitrosodiethylamine; DMBA, 7,l2-dimethylbenz[a]anthracene; TBP, TATA box binding protein.
The multiplicity of enzymatic changes seen within individual lesions and the fact that certain enzymes of the cytochrome P450 family, which generally show decreased expression levels in transformed hepatocytes, can still be induced by xenobiotics strongly suggest that the observed enzyme alterations are not due to mutational events in the underlying structural genes, but rather reflect consequences of changes in the activity of regulatory genes of a higher order (3, 4) . In a limited number of cases investigated so far, tumour-associated increases or decreases in protein expression could be correlated with concomitant changes in the steady-state concentrations of the corresponding mRNAs (5, 6) . This suggests that the alterations in protein content may result from changes in transcriptional control, which was more recently directly proven in an elegant experiment on glutathione-S-transferase P expression in transgenic rats (7) .
Tissue-specific expression of genes is based on the presence of cw-acting sequences in their promoter and enhancer regions which interact with sequence-specific nuclear transcription factors which potentiate or depress transcriptional initiation (for review see 8). The establishment and maintenance of a cell-type-specific differentiated phenotype therefore relies on the presence and activity of an array of organ-enriched DNAbinding proteins with fra/w-activating activity. In liver, several nuclear proteins -generally termed hepatocyte-enriched nuclear factors (HNFs*) -have been identified that are known to regulate the transcription of liver-specific genes (for review see 9-11). The promotor regions of several genes, including those coding for albumin, a-fetoprotein, al-antitrypsin, transthyretin, tyrosine aminotransferase and certain members of the cytochrome P450 2C family, that are highly expressed in liver have been demonstrated to contain consensus sequences that bind different HNFs, and the relative abundance of these factors determines the level of gene expression (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . The present study was therefore aimed to investigate whether the enzymatic changes observed in rodent hepato-carcinogenesis may be related to altered expression of HNFs.
The mRNA levels of six different HNFs were analysed in 24 mouse liver tumours and 13 corresponding samples from normal liver tissue which were available to us from previously performed experiments. These liver tumours had been induced in male C57BL/6J, C3H/He or B6C3F1 mice by single i.p. injection of A'-diethylnitrosamine (DEN; 10 ug/g body wt) or 7,12-dimethylbenz[a]anthracene (DMBA; 20 umol/g body wt) on days 12-15 after birth. Between 42 and 77 weeks thereafter, tumours and surrounding normal-appearing liver tissues were collected and immediately frozen in liquid nitrogen. Since mutation of the Ha-ras protooncogene is a very frequent genetic alteration in mouse liver tumours, particularly occurring in codon 61 of the gene (19), we were interested to know whether mutational activation of this growth-and differentiation-regulating gene might influence the expression of HNFs. Therefore, all liver tumours were screened for the presence of base substitutions (AAA, CGA, CTA; wild-type = CAA) at codon 61 of the Ha-ras gene by allele-specific oligonucleotide A.Kalkuhl et al hybridization of DNA fragments amplified by polymerase chain reaction using the amplification primers and oligonucleotide probes previously described (19) . The results of these analyses are summarized in Table I . For isolation of total RNA the method of Chomczynski and Sacchi (20) was used and the level of HNF-mRNAs was analysed by quantitative RNase protection assay using gene-specific probes as previously described (21) . In brief: [a-
32 P]UTP-labelled antisense RNA probes -HNF-la and P (22), HNF-3a, P and y (23), HNF-4 (24) and TATA box binding protein (TBP) (25) -were derived from Bluescript (Stratagene) subclones. The antisense probes were hybridized against 10 |ig of total RNA or tRNA as negative control at 54°C in 80% formamide overnight. The GC contents of the oligonucleotide probes were very similar, and this property allowed us to use identical conditions during incubation. Excess probes were removed by digestion with RNases A and Tl followed by a proteinase K incubation. The protected probe fragments were analysed on a denaturating 6% polyacrylamide gel and quantified by use of a Fuji phosphoimager.
RNase protection assay has the advantage over Northern analysis of increased sensitivity and offers the possibility of comparative quantitation of multiple RNAs within one and the same analysis. This also allows for simultaneous analysis of an RNA not assumed to be differentially expressed in tumours which may thus serve as an internal standard. In our study we used as reference TBP mRNA, which codes for a protein of the basic transcriptional machinery. Figure 1 shows a representative example of an autoradiogram obtained by RNase protection analysis. The positions of the probes and the protected fragments are indicated by arrows. A variety of extra bands are also visible. We believe that these bands are not 'unspecific' in the sense that additional closely related sequences are detected by the oligonucleotide probe. They may rather represent shorter fragments of probe resulting from incomplete hybridization to the mRNA species of question, which can occur as a consequence of formation of tertiary structures of the nucleic acids. The signals specific for protected HNFs and for TBP were quantified by use of a phosphoimager, and the signals obtained in the various lanes were corrected for the respective TBP signals. Since there were no significant interstrain differences in the expression of the various HNFs, data from the different strains were pooled for display and statistical analysis. A summary of the quantitative results is presented in Figure 2 . While HNF-ip, HNF-3a and HNF-3P showed unchanged expression levels, HNF-la and HNF-4 mRNAs were lowered by ~30% and ~20% respectively. By contrast, HNF-3y was increased in expression by ~50% in liver tumours when compared with the normal liver tissue. These effects were highly significant and independent of whether the tumour cells were wild-type or mutated at codon 61 of the Ha-ras gene.
Limited knowledge has been accumulated so far on changes in HNF-mRNA, protein or activity during hepatocarcinogenesis. The nuclear levels of HNF-la and HNF-4 proteins, as detected on Western blots, have been described in a recent review article (26) to be decreased in persistent nodules and even more dramatically in hepatocellular carcinomas produced in rats by the resistant hepatocyte model. Using essentially the same experimental system, Flodby et al. (27) reported on unchanged HNF-1 and HNF-4 steady-state mRNA levels but decreased levels of the corresponding proteins in rat neoplastic nodules. Decreases in HNF-la and HNF-4 mRNA were also seen in the mouse liver tumours analysed in the present study, although the overall changes were rather small in extent. Stumpf et al. (28) reported on considerable variation in binding activity of LFB1 (HNF-1) and HNF-4 as detected by gel-retardation assay in hepatocellular carcinomas of differing histological phenotype that were generated in rats by a 6 week exposure of the animals to DEN. Interestingly, LFB1 (HNF-1) and HNF-4 activities were correlated in expression, similar to our present findings. This is not unexpected, since HNF^t is known to transactivate HNF-1 (29) .
HNFs are differentially expressed in the developing rodent liver. In mice, HNF-3a, p, y peak between days 9 and 12 of gestation (30) . In adult mouse liver, the HNF-3 mRNAs are present at a ratio of 4:2:1 for y, P and a (23, see also HNF-la, (5, HNF-3a, p\ y and HNFM mRNA levels were quantified by RNase protection assay and phosphoimaging analysis. HNF-specific signals were corrected for differences in TBP-expression in the different lanes. Data represent means ± SD of 13 samples from normal liver (arbitrarily set to 1), 13 samples from tumours where no Ha-ras codon 61 mutations were detectable (Ha-ras wt) and 11 samples from Ha-ras codon 61 mutated (Ha-ras mut.) tumours. Significant differences between normal liver and liver tumours are indicated by asterisks: **P < 0.0001, *P < 0.05 (Student's (-test).
during early liver development and decreased in expression in the adult liver, while HNF-ip and HNF-3P are preferentially expressed in adult hepatocytes (31) . The tumour-associated decreases in HNF-1 and HNF-4 may therefore not be taken as indicative of reprogramming of the tumour cells in the sense of a 'retrodifferentiation'. In the normal adult liver, the expression of liver-enriched transcription factors is restricted to the hepatocytes. Under experimental conditions which produce the proliferation of oval cells, HNFs-la, (3 and 3y are also highly expressed in the proliferating cells. Oval cells are assumed to represent liver stem cells capable of differentiating into different hepatic lineages, and the additional expression of HNF-4 has been observed when the oval cells differentiate morphologically into hepatocytes (31) .
The promoters of a variety of genes, e.g. cytochromes P450 of the C2 family, which are known to be decreased in expression during mouse hepatocarcinogenesis (32) , contain functional HNF-1 and HNF-4 binding sites (14, 16, 18) . The decreases in HNF-la and HNF-4 mRNA levels in the mouse liver tumours are principally in line with the idea that liverenriched transcription factors are involved in the downregulation of cytochromes P450 and other genes which are deregulated in tumour cells, although it seems unlikely that the rather moderate decreases in HNF mRNA levels would suffice to explain the phenomenon. Functional HNF assays, which would be required to clarify this question further, are very difficult to perform due to the limited amount of tissue material available from mouse liver tumours. In conclusion, we have shown that chemically induced mouse liver tumours maintain the overall mRNA expression pattern of the liverenriched transcription factors identified so far, with significant changes in the mRNA levels of HNF-la, HNF-4 and HNF-3y.
